In World Workshop 2017, American Academy of Periodontology (AAP) and European Federation of Periodontology (EFP) with expert participants updated the 1999 classification of Periodontal Diseases.
Since 1999, new evidences have emerged regarding environmental and systemic risk factors, prompting the experts to develop new classification.
This presentation describes the gingival recession, its classifications and theories of pathogenesis and different etiological factors in its progression.
This presentation describes the gingival recession, its classifications and theories of pathogenesis and different etiological factors in its progression.
Certains medications have been associated with gingival enlargement.
the seminar gives a complete analysis of etilogy and pathogenesis involved in digo as well as sequlae of it
Furcation involvement is a common sequela of severe chronic periodontal disease. Its effective management has a profound influence on the outcome of periodontal therapy.
Systemic Peridoontology, link between systemic health and periodontology, diabetes and periodontology, Pregnancy and Peridotology,Nutrition and periodontology
Splinting is one of the oldest forms of aids to periodontal therapy. By redistribution of forces on the affected teeth the splint minimizes the effects caused by loss of support. Splinting teeth to each other allows weakened teeth to be supported by neighbouring teeth. This presentation reviews the rationale, techniques, advantages and ill effects of stabilization of teeth by splinting as an aid to periodontal therapy. With the acceptance and clinical predictability of adhesive procedures, the use of conservative bonding techniques to splint teeth offers a useful alternative to more invasive restorative procedures. Loss of tooth-supporting structures results in tooth mobility. Increased tooth mobility adversely affects function, aesthetics, and the patient’s comfort. Splints are used to overcome all these problems. When faced with the dilemma of how to manage periodontally compromised teeth, splinting of mobile teeth to stronger adjacent teeth is a viable option. This prolongs the life expectancy of loose teeth, gives stability for the periodontium to reattach, and improves comfort, function and aesthetics.
Dentists play an important role in the diagnosis and management of desquamative gingivitis. The importance of being able to recognise and properly diagnose this condition is accentuated by the fact that a serious and life threatening disease may initially manifest as desquamative gingivitis.
Phase I periodontal therapy is the first in the chronologic sequence of procedures that constitute periodontal treatment. It is also referred to as cause related therapy or non-surgical periodontal therapy.
A brief description of all topics to recent advances,SDD, host modulation and diabetes, host modulation in smokers, chemically modified tetracyclines, bisphosphonates
Certains medications have been associated with gingival enlargement.
the seminar gives a complete analysis of etilogy and pathogenesis involved in digo as well as sequlae of it
Furcation involvement is a common sequela of severe chronic periodontal disease. Its effective management has a profound influence on the outcome of periodontal therapy.
Systemic Peridoontology, link between systemic health and periodontology, diabetes and periodontology, Pregnancy and Peridotology,Nutrition and periodontology
Splinting is one of the oldest forms of aids to periodontal therapy. By redistribution of forces on the affected teeth the splint minimizes the effects caused by loss of support. Splinting teeth to each other allows weakened teeth to be supported by neighbouring teeth. This presentation reviews the rationale, techniques, advantages and ill effects of stabilization of teeth by splinting as an aid to periodontal therapy. With the acceptance and clinical predictability of adhesive procedures, the use of conservative bonding techniques to splint teeth offers a useful alternative to more invasive restorative procedures. Loss of tooth-supporting structures results in tooth mobility. Increased tooth mobility adversely affects function, aesthetics, and the patient’s comfort. Splints are used to overcome all these problems. When faced with the dilemma of how to manage periodontally compromised teeth, splinting of mobile teeth to stronger adjacent teeth is a viable option. This prolongs the life expectancy of loose teeth, gives stability for the periodontium to reattach, and improves comfort, function and aesthetics.
Dentists play an important role in the diagnosis and management of desquamative gingivitis. The importance of being able to recognise and properly diagnose this condition is accentuated by the fact that a serious and life threatening disease may initially manifest as desquamative gingivitis.
Phase I periodontal therapy is the first in the chronologic sequence of procedures that constitute periodontal treatment. It is also referred to as cause related therapy or non-surgical periodontal therapy.
A brief description of all topics to recent advances,SDD, host modulation and diabetes, host modulation in smokers, chemically modified tetracyclines, bisphosphonates
Classification of periodontal diseases 2 /certified fixed orthodontic courses...Indian dental academy
Welcome to Indian Dental Academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy has a unique training program & curriculum that provides students with exceptional clinical skills and enabling them to return to their office with high level confidence and start treating patients
State of the art comprehensive training-Faculty of world wide repute &Very affordable.
Classification of periodontal diseases /certified fixed orthodontic courses...Indian dental academy
Welcome to Indian Dental Academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy has a unique training program & curriculum that provides students with exceptional clinical skills and enabling them to return to their office with high level confidence and start treating patients
State of the art comprehensive training-Faculty of world wide repute &Very affordable
Premalignantlesions and conditions by Dr. Amit T. Suryawanshi, Oral Surgeon,...All Good Things
Hi. This is Dr. Amit T. Suryawanshi. Oral & Maxillofacial surgeon from Pune, India. I am here on slideshare.com to share some of my own presentations presented at various levels in the field of OMFS. Hope this would somehow be helpful to you making your presentations. All the best.
Classification of chemical antiplaque agents
1. FIRST GENERATION AGENTS
Poor substantivity and thus used 4-6 times daily.
Reduces plaque score by 20-50%
Examples:
Antibiotics like Penicillin, Erythromycin, Metronidazole
2. SECOND GENERATION AGENTS
Reduce plaque score by 70-90%
Used twice daily
Example: Bisbiguanides, Chlorhexidine, Alexidine
3. THIRD GENERATION AGENTS
Effective against specific periodontal pathogens
Example: Delmopinol
II. Vehicles for delivery of chemical agents
a. Toothpastes
b. Sprays
c. Irrigators
d. Chewing gums
e. Mouthwashes (Listerine, Chlorhexidine, Triclosan, Fluorides, Hydrogen peroxides, Povidone iodine)
Analgesic is a drug that relieves pain by acting on the CNS or on the peripheral pain mechanism without altering consciousness
Opioid analgesics
Non Opioid analgesics (NSAIDs)
NSAIDs are non-steroidal anti-inflammatory drugs. These are not only pain killers but also are anti-inflammatory drugs that are widely used in dentistry. These are weaker analgesics, also called nonnarcotic or aspirin-like or antipyretic analgesics. They do not depress CNS, do not produce physical dependence, and have no abuse liability. They act primarily on peripheral pain mechanisms.
It is a naturally occurring, semi-synthetic, or synthetic type of anti-infective agent that destroys or inhibits the growth of selective microorganisms, generally at low concentrations.
These drugs are used extensively in dentistry for two main reasons: to prevent an infection (chemoprophylaxis) and in the treatment of an infection. Their use in the management of periodontal diseases is often as an adjunct to conventional treatment.
INDICATIONS IN PERIODONTAL DISEASES
1. Patients who do not respond to conventional mechanical periodontal therapy
2. Patients with Aggressive periodontitis and other types of early-onset periodontitis
3. Patients with acute or recurrent periodontal infection
(Periodontal abscess, NUG / NUP, Peri-implantitis, Pericoronitis) associated with/without systemic manifestation)
4. Prophylaxis for medically compromised patients, endocarditis
Soft deposit that form the biofilm on teeth. Plaque is defined as structured, resilient, yellow grayish colored substance that adheres tenaciously to intra oral hard surfaces including restorations. The term plaque is derived from French word, meaning ‘to form a coverage’.Marginal plaque – cause gingivitis.
Supragingival plaque and tooth-associated subgingival plaque – cause calculus formation and root caries. Tissue-associated subgingival plaque- cause tissue destruction in periodontitis.
Cementum is the mineralized dental tissue covering the anatomical root of teeth. It begins at the cervical portion of the tooth at the cementoenamel junction till the apex. It is one of the four tissues that support the tooth in the jaw (the periodontium).
The primary function- Provides attachment to collagen fibres of the periodontal ligament. It therefore is a highly responsive tissue maintaining the integrity of the root, helping to maintain the tooth in its functional position in the mouth, and being involved in tooth repair and regeneration.
Recent advances in periodontal diagnosisPerio Files
First generation:- Conventional probes.
Second generation:- Pressure controlled visual measurement recording probes
Third generation:-Pressure controlled electronic probes with direct computer data capture.
Fourth generation : Aim at recording sequential probing positions along the gingival sulcus.
Fifth generation : Ultrasonic device attached to the 4th generation probe.
Hormonal changes in female patients and periodontal diseasesPerio Files
Hormonal fluctuations and gingival changes in female patient occurs during Puberty, Menstruation, Pregnancy, Menopause,
Oral Contraceptives, Osteoporosis.
NEED FOR ASSESSMENT: To identify high-risk stages of female patients in prior so that preventive and treatment procedures can be tailored
During pregnancy, women undergo certain hormonal and physiological changes that can affect their mouths.
EFFECT OF PREGNANCY ON PERIODONTAL TISSUES
PREGNANCY GINGIVITIS
EFFECT OF PERIODONTITIS ON PREGNANCY
PRETERM LOW BIRTH WEIGHT (PLBW) INFANTS
PREECLAMPSIA
Oral-systemic link has been termed Periodontal Medicine. Significance: Periodontal disease is preventable and readily treatable, thus providing many new opportunities for preventing and improving several systemic diseases.
FOCAL INFECTION: Localized or Generalized infection caused by dissemination of microorganisms or toxic products from focus of infection.
FOCUS OF INFECTION Confined area that
(1) contains pathogenic microorganisms
(2) can occur anywhere in body
Diseases/Conditions affected by periodontitis
A PREGNANCY, PREECLAMPSIA
B ISCHEMIC HEART DISEASES, STROKE
C DIABETES MELLITUS
D PNEUMONIA, COPD
E OSTEOPOROSIS
F CANCER
G ALZHEIMER’S DISEASE
H. RHEUMATOID ARTHRITIS
*Increase in size of gingiva. Lead to false pockets.
*Difficulties associated with it are:
Difficulty in plaque control; Aesthetic concerns; Affect mastication
Interfere with speech
*TREATMENT:
Gingivectomy is the treatment of choice to remove false pockets.
In case of true pockets (osseous defects), gingivectomy with Flap surgery is done. First Gingivectomy is done. After that flap is raised and osseous surgery is performed (either osteotomy or regenerative depending upon the type of defect). Gingivectomy is done by scalpel or electro cautery/lasers (to minimize bleeding). Gingivectomy can be done only where at least 3mm of keratinized gingiva remains after completion of surgery. So it is contraindicated in patients with lack of sufficient keratinized gingiva
*REASONS OF RECURRENCE:
Responsible factors: Residual local irritation; and systemic or hereditary conditions causing noninflammatory gingival hyperplasia.
Recurrence of chronic inflammatory enlargements immediately after treatment indicates that all irritants have not been removed. Contributory local conditions like food impaction and overhanging margins of restorations are commonly overlooked.
If the enlargement recurs after healing is complete and normal contour is attained, inadequate plaque control by the patient is the most common cause.
All about gingivitis
*definition
*classification
*Signs and Symptoms: Increased GCF, Gingival Bleeding, Color change, Consistency, Surface texture (STIPPLING), Position of Gingiva, Gingival Contour, Size.
Treatment consisits of scaling and root planing. The more inflamed a gingival unit appears clinically, the better the chances of therapeutic measures resulting in a return to normal gingival health
All furcation defects need to be classified and their possible prognosis should be defined. The treatment of the furcation defects should be carried out accordingly. Treatment include
Osteoplasty, Odontoplasty, Tunnel preparation, Root resection, Hemisection
A brief description of all topics to recent advances,SDD, host modulation and diabetes, host modulation in smokers, chemically modified tetracyclines, bisphosphonates
It restore alveolar bone to the level existing at the time of surgery or slightly more apical to this level. Aim is to achieve positive bony architecture.
STEPS INCLUDE:
1.VERTICAL GROOVING
2. RADICULAR BLENDING
3. FLATTENING INTERPROXIMAL BONE
4. GRADUALIZING MARGINAL BONE
PREFERRED TREATMENT FOR ONE WALLED PERIODONTAL BONE DEFECTS (HEMISEPTUM)
Evidence based practice is Integration of best research evidence with clinical expertise and patient values.
Advantages: QUALITY OF CLINICAL PRACTICE IMPROVES BY INCORPORATING LATEST EFFECTIVE CLINICAL TECHNIQUES INTO PATIENT CARE.
Dental practitioner should try to adopt quality evidences in dental practice, accept evidence based new practices and letting go existing theories.
Evidence collected should be combined with clinical experience and patient preferences. Positive environment with advancement in science can help facilitate evidence based change in future.
The future of dentistry and periodontics lies in regeneration. The goals of periodontal therapy lies in not only the arrest of periodontal disease progression but also regeneration of the lost periodontal structures. This presentation provides a review of the current understanding of the regeneration of the periodontium and the procedures involved to restore the periodontal tissues around the teeth.
This topic include all the drugs that are locally applied in periodontal pocket so that their levels in GCF should be more than blood.
Advantages:
Can attain higher concentrations at base of pocket
Can use drugs that are not suitable for systemic administration
Patient compliance is not required
Alternative for patients predisposed to adverse drug reactions from systemic administration.
Reduced risk for drug resistant microbe development
Lower total drug dose
INDICATIONS:
As an adjunct to mechanical therapy in pockets of 5 mm or greater depth
In patients who are systemically compromised & cannot undergo periodontal flap surgery
Localized recurrent pockets with supportive periodontal therapy
In refractory periodontitis (that is resistant to treatment)
Inflammation and Immunity in periodontitis pptPerio Files
Local destruction of periodontium occurs mostly by activation of immune and inflammatory response, initiated by plaque. First innate immune response is activated followed by specific immune response.
Useful for BDS and MDS students
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
4. INDEX
PERIODONTAL DISEASES AND CONDITIONS (3 types)
I. Periodontal health, gingival diseases and conditions
1. Periodontal health and gingival health (a. Clinical gingival health on an intact periodontium; b. Clinical gingival health
on a reduced periodontium)
2. Gingivitis: dental biofilm induced (a. Associated with dental biofilm alone; b. Mediated by systemic or local risk factors;
c. Drug-influenced gingival enlargement)
3. Gingival diseases: non-dental biofilm-induced (1. Genetic or developmental disorder; 2. Specific infections; 3.
Inflammatory and immune conditions; 4. Reactive processes; 5. Neoplasms; 6. Endocrine, nutritional and metabolic
diseases; 7. Traumatic lesions; 8.Gingival Pigmentation)
II. Periodontitis
1. Necrotizing Periodontal Diseases (a. Necrotizing Gingivitis; b. Necrotizing Periodontitis; c. Necrotizing Stomatitis)
2. Periodontitis as a Manifestation of Systemic Disease (1.Genetic disorders; 2.Systemic disorders that influence the
pathogenesis of periodontal diseases)
3. Periodontitis (a. Stages; b. Extent and distribution; c. Grades)
5. INDEX
III. Other conditions affecting the periodontium
1. Systemic diseases affect periodontium independent of dental plaque
biofilm induced periodontitis (a. Neoplasms; b. Other disorders)
2. Other Periodontal Conditions (a. Periodontal abscesses; b. Endodontic
Periodontal lesions)
3. Mucogingival Deformities and Conditions (a. Gingival phenotype;
b.Gingival /soft tissue recession; c. Lack of gingiva; d. Decreased vestibular
depth; e. Aberrant frenum/muscle position; f. Gingival excess; g. Abnormal
color; h. Condition of exposed root surface)
4. Traumatic Occlusal Forces (a. Primary occlusal trauma; b. Secondary
occlusal trauma; c. Orthodontic forces)
5. . Prosthesis and Tooth Related Factors that modify or predispose to
plaque-induced gingival diseases/periodontitis (a. Localized tooth related
factors; b. Localized dental prosthesis-related factors)
6. INDEX
Peri-implant Diseases and Conditions
I. Peri-implant Health
II. Peri-implant Mucositis
III. Peri-implantitis
IV. Peri-implant Soft and Hard Tissue Deficiencies
Explanations
7. INTRODUCTION
• In World Workshop 2017, American Academy of
Periodontology (AAP) and European Federation of
Periodontology (EFP) with expert participants updated the
1999 classification of Periodontal Diseases.
• Since 1999, new evidences have emerged regarding
environmental and systemic risk factors, prompting the
experts to develop new classification.
11. PERIODONTAL DISEASES AND CONDITIONS is
divided into 3 categories
I. PERIODONTAL HEALTH, GINGIVAL
DISEASES AND CONDITIONS (all in blue
and red)
II. PERIODONTITIS (all in black)
III. OTHER CONDITIONS AFFECTING THE
PERIODONTIUM (all in yellow)
12. I. Periodontal health, gingival diseases and
conditions
1. Periodontal health and gingival health (a. Clinical gingival health on
an intact periodontium; b. Clinical gingival health on a reduced
periodontium)
2. Gingivitis: dental biofilm induced (a. Associated with dental biofilm
alone; b. Mediated by systemic or local risk factors; c. Drug-
influenced gingival enlargement)
3. Gingival diseases: non-dental biofilm-induced (1. Genetic or
developmental disorder; 2. Specific infections; 3. Inflammatory and
immune conditions; 4. Reactive processes; 5. Neoplasms; 6.
Endocrine, nutritional and metabolic diseases; 7. Traumatic
lesions; 8.Gingival Pigmentation)
13. 1. PERIODONTAL HEALTH AND GINGIVAL
HEALTH
(2 categories))
a. Clinical gingival health on an intact periodontium
b. Clinical gingival health on a reduced periodontium
i. Stable periodontitis patient
ii. Non-periodontitis patient
14. 2. GINGIVITIS: DENTAL BIOFILM INDUCED
(3 categories)
a. Associated with dental biofilm
alone
15. b. Mediated by systemic or local risk factors
i) Systemic risk factors a. Smoking
b. Hyperglycemia
c. Nutritional factors
d. Pharmacological (prescription, non prescription)
e. Sex Steroid hormones
(Puberty, pregnancy, Menstrual cycle, oral contraceptives)
f. Hematological agents
ii) Local risk factors
a. Dental plaque biofilm retention factors
(prominent restoration margins)
b. Oral dryness
17. 3. GINGIVAL DISEASES: NON-DENTAL
BIOFILM-INDUCED
(8 categories)
1. Genetic or developmental disorder
1.1 Hereditary Gingival fibromatosis
2. Specific infections
2.1 Bacterial infections
a) Necrotizing Periodontal disease
b) Neisseria Gonorrhoeae (gonorrhea)
c) Treponema pallidum (syphlis)
d) Mycobacterium tuberculosis (tuberculosis)
e) Streptococcal gingivitis (strains of streptococcus)
18. b.2 Viral origin-
a) Coxsachie virus (Hand foot and mouth disease
b) Herpes simplex virus; HSV1,2 (primary or recurrent)
c) Varicella zoster virus (chicken pox)
d) Molluscum contagiosum
e) Human papilloma virus
b.3 Fungal-
a) Candidiasis
b) Other mycosis (eg. Histoplasmosis, aspergillosis)
19. 3. Inflammatory and immune conditions
3.1 Hypersensitivity reaction-
a) Contact allergy
b) Plasma cell gingivitis
c) Erythema multiforme
3.2 Auto immune diseases of skin and mucous membrane-
a) Pemphigus vulgaris
b) Pemphigoid
c) Lichen Planus
d) Lupus erythematosis
20. 3.3 Granulomatous inflammatory condition-
a) Crohn’s disease
b) Sarcoidosis
4. Reactive processes
4.1 Epulidus
a) Fibrous epulis
b) Calcifying fibroblastic granuloma
c) Pyogenic granuloma
d) Peripheral giant cell granuloma (or central)
22. 6. Endocrine, nutritional and metabolic diseases
6.1 Vitamin deficiency
a) Vitamin C deficiency (Scurvy)
7. Traumatic lesions
7.1 Physical and mechanical insults
a) Frictional Keratosis
b) Tooth brushing induced gingival abrasions
c) Factitious injury (self harm)
23. 7.2 Chemical insults
a) Etching
b) Chlorhexidine
c) Acetyl salicylic acid
d) Cocaine
e) Hydrogen peroxide
f) Dentifrice detergent
g) Paraformaldehyde/ calcium hydroxide
7.3 Thermal insults
a) Burn of mucosa
24. 8. Gingival pigmentation
a) Melanoplakia
b) Smoker’s melanosis
c) Drug induced pigmentation
(antimalarial; minocycline)
d) Amalgam tattoo
25. II. Periodontitis
1. Necrotizing Periodontal Diseases (a.
Necrotizing Gingivitis; b.Necrotizing
Periodontitis; c.Necrotizing Stomatitis)
2. Periodontitis as a Manifestation of Systemic
Disease (1.Genetic disorders; 2.Systemic
disorders that influence the pathogenesis of
periodontal diseases)
3. Periodontitis (a. Stages; b. Extent and
distribution; c. Grades)
27. 2. Periodontitis as a Manifestation of
Systemic Disease
Classification under it should be according to
the systemic disease (according to
INTERNATIONAL STATISTICAL
CLASSIFICATION OF DISEASES AND
RELATED HEALTH PROBLEMS (ICD)
codes)
Following are the diseases that cause severe
periodontitis in early stages
28. 2. Periodontitis as a Manifestation of
Systemic Disease
Classification under it should be according to
the systemic disease (according to
INTERNATIONAL STATISTICAL
CLASSIFICATION OF DISEASES AND
RELATED HEALTH PROBLEMS (ICD)
codes)
Following are the diseases that cause severe
periodontitis in early stages:
33. 2. Systemic disorders that influence
the pathogenesis of periodontal
diseases
Emotional stress and depression
Smoking (nicotine dependence)
Medication
Inflammatory bowel disease
Arthritis (rheumatoid arthritis, osteoarthritis)
34. 3. Periodontitis
a. STAGES: Based on Severity and Complexity
of Management
Stage I: Initial Periodontitis
Stage II: Moderate Periodontitis
Stage III: Severe Periodontitis with potential for
additional tooth loss
Stage IV: Severe Periodontitis with potential for loss
of dentition
35. b. Extent and distribution:
Localized
Generalized
Molar-incisor distribution
36. c. Grades: Risk of rapid progression, anticipated
treatment response
i. Grade A: Slow rate of progression
ii. Grade B: Moderate rate of progression
iii. Grade C: Rapid rate of progression
37. 3. OTHER CONDITIONS AFFECTING THE
PERIODONTAL SUPPORTING TISSUES
1. Systemic diseases affect periodontium independent of dental plaque biofilm
induced periodontitis (a. Neoplasms; b. Other disorders)
2. Other periodontal conditions (a. Periodontal abscesses; b. Endodontic
Periodontal lesions)
3. Mucogingival Deformities and Conditions (a. Gingival phenotype; b.Gingival
/soft tissue recession; c. Lack of gingiva; d. Decreased vestibular depth; e.
Aberrant frenum/muscle position; f. Gingival excess; g. Abnormal color; h.
Condition of exposed root surface)
4. Traumatic Occlusal Forces (a. Primary occlusal trauma; b. Secondary
occlusal trauma; c. Orthodontic forces)
5. . Prosthesis and Tooth Related Factors that modify or predispose to plaque-
induced gingival diseases/periodontitis (a. Localized tooth related factors; b.
Localized dental prosthesis-related factors)
38. 1. Systemic diseases affect periodontium
independent of dental plaque biofilm
induced periodontitis
Classification under it should be
according to the systemic disease
Following are the diseases:
39. a. NEOPLASMS
• PRIMARY NEOPLASTIC DISEASE OF
PERIODONTAL TISSUE
Oral squamous cell carcinoma Odontogenic tumors
Other primary neoplasms of periodontal tissues
• Secondary metaplastic neoplasms of
periodontal tissues
40. b. OTHER DISORDERS THAT MAY AFFECT
PERIODONTAL TISSUES
Granulomatosis with polyangitis
Langerhans cells histiocytosis
Giant cell granulomas
Hyperparathyroidism
Systemic sclerosis (scleroderma)
Vanishing bone disease (Gorham- Stout syndrome)
41. 2. Other periodontal conditions
a. Periodontal abscesses
b. Endodontic Periodontal lesions
42. 3. Mucogingival
Deformities and
Conditions
a. Gingival phenotype
b. Gingival /soft tissue recession
c. Lack of gingiva
d. Decreased vestibular depth
e. Aberrant frenum/muscle position
f. Gingival excess
g. Abnormal color
h. Condition of exposed root surface
46. II. Peri-implant Diseases
and Conditions
I. Peri-implant Health
II. Peri-implant Mucositis
III. Peri-implantitis
IV. Peri-implant Soft and Hard Tissue
Deficiencies
48. New terminologies including
Periodontal health and gingival health
are introduced.
Periodontal health divided into intact
and reduced periodontal health.
49. Intact periodontal health means
Patient with no clinical attachment
loss or radiographic bone loss
Less than 10% sites with bleeding on
probing and pocket depth ≤3mm
50. Reduced periodontium
means:(two conditions)
1. Due to non- periodontitis conditions
like gingival recession and crown
lengthening procedures.
Less than 10% sites with bleeding on
probing and pocket depth ≤3mm
51. Reduced periodontium means:
2. In successfully treated periodontitis
patients, pocket probing depth upto
4mm and no bleeding on probing (BOP)
at 4mm site is considered as gingival
healthy state.
52. Gingival inflammation is more
appropriate term for gingival
inflammation in periodontitis patient
rather than gingivitis; as patient cannot
be defined as case of periodontitis and
gingivitis at same time.
54. Diagnosed Periodontitis patient is considered as
periodontitis throughout the life and based on
response of periodontal therapy divided into
a. Controlled (healthy/stable)
b. Remission (showing gingival inflammation)
c. Uncontrolled (unstable or recurrent periodontitis)
55. 1. Necrotizing Periodontal Diseases
Term ‘Necrotizing Stomatitis’ has been
introduced.
It is caused by extension of necrosis beyond
the mucogingival junction.
Term ulceration has been retracted from
classification as it is considered secondary
to necrosis.
56. 2. Periodontitis as a Manifestation of
Systemic Disease
Classification under it should be
according to the systemic disease
It include the diseases that cause
severe periodontitis in early stages
57. Neoplasms
10% of squamous cell carcinoma
arises in gingiva and resemble
localized periodontitis or acute
periodontitis with redness, swelling,
increased pocket depth and bone
loss
58. Emotional stress, Depression,
Hypertension
Animal studies have revealed that stress
and depression may potentiate
periodontal breakdown
Evidences regarding association
between hypertension and periodontal
disease is inconclusive
59. Medications
Cytotoxic drugs given for malignancies cause
neutropenia, that can cause destructive periodontitis,
however more studies are awaited.
Other drugs like Bisphosphonates and anti
inflammatory therapy (anti TNF therapy, NSAIDS)
decrease level of destructive periodontitis.
60. 3. Periodontitis
Terms Chronic and Aggressive
Periodontitis have been eliminated in
this classification (due to lack of clear
cut demarcation between two) and only
term Periodontitis has been used
61. A person is said to have Periodontitis
when:
Interdental clinical attachment loss
(CAL) is measurable at ≥2 non-
adjacent teeth
Buccal clinical attachment loss (CAL)
of ≥3mm with pocket depth >3mm is
measurable at ≥2 teeth
62. In this clinical attachment loss (CAL)
occurring due to non-periodontal
conditions is excluded like:
gingival recession due to trauma
Caries extending to cervical region of
tooth
Drainage of endo lesion through
marginal periodontium resulting in
periodontitis
Distal of 2nd molar due to extraction
or malpositioning of 3rd molar
63. Stage and Grading in
Periodontitis
Stage depicts the extent and severity
of disease
Grading depicts the rate of
progression of periodontitis
64. Stage I.
Severity: Interdental clinical attachment loss: 1-2mm
Radiographic bone loss: Coronal third (<15%)
No tooth loss due to periodontitis
Complexity: Max probing depth ≤4mm
Mostly Horizontal Bone Loss
Extent and Distribution: Localized- <30% teeth involved;
Generalized; or
Molar/incisor pattern
65. Stage II.
Severity: Interdental clinical attachment loss: 3-4mm
Radiographic bone loss: Coronal third (15%-33%)
No tooth loss due to periodontitis
Complexity: Max probing depth ≤5mm
Mostly Horizontal Bone Loss
Extent and Distribution: Localized- <30% teeth involved;
Generalized; or
Molar/incisor pattern
66. Stage III.
Stage III.
Severity: Interdental clinical attachment loss: ≥5mm
Radiographic bone loss: Extending to middle third of root and beyond
Tooth loss due to periodontitis: ≤4
Complexity: In addition to Stage II: Probing depth ≥6mm
Vertical Bone Loss ≥3mm
Furcation involvement class II, III
Moderate Ridge defects
Extent and Distribution: Localized- <30% teeth involved;
Generalized; or
Molar/incisor pattern
67. Stage IV.
Severity: Interdental clinical attachment loss: ≥5mm
Radiographic bone loss: Extending to middle third of root and beyond
Tooth loss due to periodontitis: ≥5 teeth
Complexity: In addition to Stage III -Need for complex rehabilitation due to
- Masticatory insufficiency
-secondary occlusal trauma (tooth mobility degree ≥2)
-Severe Ridge defects
-Bite collapse, drifting, flaring
- < 20 remaining teeth (10 opossing pairs)
Extent and Distribution: Localized- <30% teeth involved;
Generalized; or
Molar/incisor pattern
68. GRADING
Indicate rate of progression of
periodontitis, responsiveness to
treatment and impact on systemic
health.
69. GRADE A: Slow rate
Radiographic bone loss/CAL: No loss over 5 years
%bone loss: <0.25
Heavy deposition of biofilm with lower levels of destruction
Risk factors:
• Smoking: Non-smoker: <10 cigarettes/day
• Diabetes: no diagnosis of diabetes
70. GRADE B: Moderate rate
Radiographic bone loss/CAL: <2mm over 5 years
%bone loss: 0.25 to 1.0
Destruction proportionate with amount of biofilm
Risk factors:
• Smoking: <10 cigarettes/day
• Diabetes: HbA1c <7.0%
71. GRADE C: Rapid rate
Radiographic bone loss/CAL: ≥2mm over 5 years
%bone loss: >1.0
Destruction more than expected than with amount of biofilm; clinical
patterns suggestive of early onset disease or/and period of rapid
progression
Risk factors:
• Smoking: ≥10 cigarettes/day
• Diabetes: HbA1c ≥7.0%
72. Diabetes
Diabetes associated periodontitis is not
a distinct disease. It along with smoking
are modifying factors; so diagnosed
under Periodontitis
Level of glycemic control and smoking
influence the grading of periodontitis.
73. Periodontal abscesses
Term gingival abscess, pericoronal abscess are
not used as separate terms in recent
classification
Thus only ‘Periodontal abscess’ term has been
used.
75. Mucogingival Deformities
and Conditions
New classification of Gingival Recession has been introduced
Recession type-1: No interproximal CAL loss, interproximal
cementoenamel junction (CEJ) not visible
Recession type-2: Interproximal CAL loss, interproximal CAL loss equal or
less than buccal CAL loss
Recession type-3: Interproximal CAL loss, interproximal CAL loss greater
than buccal CAL loss
76. TRAUMATIC OCCLUSAL
FORCES
Traumatic occlusal force replaces the term
‘excessive occlusal force’ used in previous
classification
Any occlusal force resulting in injury to tooth
and/or periodontal attachment apparatus is called
traumatic occlusal forces
77. TRAUMATIC OCCLUSAL
FORCES
Traumatic occlusal force do not cause attachment
loss, recession or non-carious cervical lesions (no
reported evidence)
It causes adaptive mobility in teeth with normal
support and progressive mobility in teeth with
reduced support, thus requiring splinting.
78. OCCLUSAL TRAUMA
Occlusal trauma is injury to periodontal ligament, cementum and alveolar
bone due to occlusal forces. It is a histological term. Symptoms are
progressive tooth mobility, widened periodontal ligament (radiographically),
adaptive tooth mobility (fremitus), root resorption, pain, discomfort on
chewing.
Primary occlusal trauma resulted in tissue injury in normal periodontium
due to traumatic forces resulting in adaptive mobility, which is not
progressive.
Secondary occlusal trauma results in tissue injury in reduced periodontium,
causing progressive mobility, tooth migration, pain that require splinting.
79. ORTHODONTIC FORCES
Animal studies suggested that certain orthodontic
forces can result in gingival recession, root
resorption, alveolar bone loss, pulpal disorders.
Good plaque control can result in successful
orthodontic tooth movements even in reduced
healthy periodontium
80. Prosthesis and Tooth Related Factors that
modify or predispose to plaque-induced
gingival diseases/periodontitis
Prosthesis and tooth related factors have been expanded in
new classification
Term ‘Biologic width’ replaced by ‘Supracrestal tissue
attachment.’ Histologically it consist of junctional epithelium
and supracrestal connective tissue attachment.
‘Altered tooth eruption’ has been introduced under tooth
related factors
81. Prosthesis and Tooth Related Factors that
modify or predispose to plaque-induced
gingival diseases/periodontitis
Data indicated that procedures
involved in fabrication of indirect
restorations can cause gingival
recessions and loss of clinical
attachment.
82. Peri-implant Disease and
Conditions
It has been introduced
Bleeding on probing differentiate between
peri-implant healthy and inflamed mucosa
Bone loss differentiate between peri-
implant mucositis and peri-implantitis
83. Peri-implant Disease and
Conditions
Peri-implant health: Absence of all clinical signs of
inflammation like bleeding on probing (BOP), swelling,
redness. It can occur around implants with healthy and
reduced bone.
Peri-implant mucositis: Inflammation in soft tissues around
implants with no bone loss. Condition is reversible. Main
causative agent is plaque. It can be reversed by eliminating
plaque. It precedes Peri-implantitis
84. Peri-implant Disease and
Conditions
Peri-implantitis: Inflammation in soft tissues
around implants with loss of supporting bone.
BOP and/or suppuration, bone level ≥3mm apical
to most coronal part of intra-osseous part of
implant are diagnostic features of peri-implantitis.
Risk of peri-implantitis is higher in patients having
history of periodontitis.
85. Ridge Deficiencies
After tooth loss, normal healing results in reduced dimensions of alveolar
ridges. It results in both hard and soft tissue ridge deficiencies.
Large ridge deficiencies occur due to:
Local cause: Traumatic extractions, severe periodontal bone loss, thin
buccal bone, injury, tooth malpositioning, endodontic infections,
removable/faulty prosthesis.
Systemic causes: medications and systemic diseases causing
osteoporosis.